Financhill
Back

QinetiQ Group plc Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison

Buy
69

QNTQY
QinetiQ Group plc

Last Price:
$27.44
Seasonality Move:
4.81%
Sell
34

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$54.95
Seasonality Move:
-11.9%
Buy
69
QinetiQ Group plc (QNTQY) is a Buy

Is QinetiQ Group plc a Buy, Sell or Hold?

  • The current QinetiQ Group plc [QNTQY] share price is $26.69. The Score for QNTQY is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • QNTQY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.24. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

QNTQY Stock Price Chart

What is QinetiQ Group plc's stock price today?

  • The QinetiQ Group plc share price today is $26.69
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QNTQY is experiencing slight selling pressure.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals, Inc.'s stock price today?

  • The Crinetics Pharmaceuticals, Inc. share price today is $53.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.

QNTQY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.42 Buy
Relative Strength Index (14 RSI): 76.6 Buy
Chaikin Money Flow: -771 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.25 - 24.97) Buy
Bollinger Bands (100): (23.21 - 27.53) Buy

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.28 Buy
Relative Strength Index (14 RSI): 65.68 Buy
Chaikin Money Flow: -209678 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.25 - 50.15) Buy
Bollinger Bands (100): (35.32 - 47.44) Buy

QNTQY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.13 Buy
20-day SMA: 24.01 Buy
50-day SMA: 23.72 Buy
200-day SMA: 25.17 Buy
8-day EMA: 24.75 Buy
20-day EMA: 18.73 Buy
50-day EMA: 10.53 Buy
200-day EMA: 3.19 Buy

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.77 Buy
20-day SMA: 48.57 Buy
50-day SMA: 45.67 Buy
200-day SMA: 36.1 Buy
8-day EMA: 49.69 Buy
20-day EMA: 48.35 Buy
50-day EMA: 45.87 Buy
200-day EMA: 40.28 Buy

QinetiQ Group plc Earnings Growth & QNTQY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.

QinetiQ Group plc Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):